Brief: Centogene And Evotec Discover Promising New Molecule To Treat Gaucher Disease

Crown LiquidationCo NV in liquidatie

14/05/2024 13:53

May 14 (Reuters) - Centogene NV  39K.MU :
    * CENTOGENE AND EVOTEC DISCOVER PROMISING NEW MOLECULE TO
TREAT
GAUCHER DISEASE
    * CENTOGENE NV - CENTOGENE TO RECEIVE LICENSE FEE PROVIDING
EVOTEC
WITH RESEARCH AND DEVELOPMENT LICENSE TO COMPLETE NEXT PHASE OF
PRE-CLINICAL RESEARCH
    * CENTOGENE NV - COMPANIES AMEND EXISTING DRUG DISCOVERY
PARTNERSHIP FOR EVOTEC TO LEAD CONTINUED DEVELOPMENT
    * CENTOGENE NV - UPON EVOTEC EXERCISING ITS OPTION,
CENTOGENE TO
RECEIVE AN OPTION EXERCISE FEE AND OTHER POTENTIAL MILESTONE
PAYMENTS AND ROYALTIES

Source text for Eikon:  ID:n0001104659-24-060910 
Further company coverage:  39K.MU 

 ((Reuters.Briefs@thomsonreuters.com;))